-
1
-
-
77956495728
-
Ovarian cancer development and metastasis
-
doi: 10.2353/ajpath.2010.100105
-
Lengyel E. Ovarian cancer development and metastasis. Am J Pathol (2010) 177(3):1053-64. doi: 10.2353/ajpath.2010.100105
-
(2010)
Am J Pathol
, vol.177
, Issue.3
, pp. 1053-1064
-
-
Lengyel, E.1
-
2
-
-
84875419233
-
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
-
doi:10.1038/nrc3432
-
Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer (2013) 13(4):273-82. doi:10.1038/nrc3432
-
(2013)
Nat Rev Cancer
, vol.13
, Issue.4
, pp. 273-282
-
-
Kipps, E.1
Tan, D.S.2
Kaye, S.B.3
-
3
-
-
34447298354
-
Pattern and prognostic factors in patients with malignant ascites: a retrospective study
-
doi:10.1093/annonc/mdl499
-
Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol (2007) 18(5):945-9. doi:10.1093/annonc/mdl499
-
(2007)
Ann Oncol
, vol.18
, Issue.5
, pp. 945-949
-
-
Ayantunde, A.A.1
Parsons, S.L.2
-
4
-
-
18944402351
-
Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma
-
doi:10.1038/sj.bjc.6602495
-
Ahmed N, Riley C, Oliva K, Rice G, Quinn M. Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Br J Cancer (2005) 92(8):1475-85. doi:10.1038/sj.bjc.6602495
-
(2005)
Br J Cancer
, vol.92
, Issue.8
, pp. 1475-1485
-
-
Ahmed, N.1
Riley, C.2
Oliva, K.3
Rice, G.4
Quinn, M.5
-
5
-
-
0141995796
-
Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid
-
doi:10.1002/path.1441
-
Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol (2003) 201(2):229-37. doi:10.1002/path.1441
-
(2003)
J Pathol
, vol.201
, Issue.2
, pp. 229-237
-
-
Ahmed, N.1
Riley, C.2
Oliva, K.3
Stutt, E.4
Rice, G.E.5
Quinn, M.A.6
-
6
-
-
34548092116
-
Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells
-
doi:10.1002/ijc.22840
-
Lane D, Robert V, Grondin R, Rancourt C, Piche A. Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells. Int J Cancer (2007) 121(6):1227-37. doi:10.1002/ijc.22840
-
(2007)
Int J Cancer
, vol.121
, Issue.6
, pp. 1227-1237
-
-
Lane, D.1
Robert, V.2
Grondin, R.3
Rancourt, C.4
Piche, A.5
-
7
-
-
18344380440
-
Ovarian cancer metastasis: integrating insights from disparate model organisms
-
doi:10.1038/nrc1611
-
Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer (2005) 5(5):355-66. doi:10.1038/nrc1611
-
(2005)
Nat Rev Cancer
, vol.5
, Issue.5
, pp. 355-366
-
-
Naora, H.1
Montell, D.J.2
-
8
-
-
35848946387
-
Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm
-
doi:10.1002/jcp.21240
-
Ahmed N, Thompson EW, Quinn MA. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol (2007) 213(3):581-8. doi:10.1002/jcp.21240
-
(2007)
J Cell Physiol
, vol.213
, Issue.3
, pp. 581-588
-
-
Ahmed, N.1
Thompson, E.W.2
Quinn, M.A.3
-
9
-
-
33644838275
-
Disaggregation and invasion of ovarian carcinoma ascites spheroids
-
doi:10.1186/1479-5876-4-6
-
Burleson KM, Boente MP, Pambuccian SE, Skubitz AP. Disaggregation and invasion of ovarian carcinoma ascites spheroids. J Transl Med (2006) 4:6. doi:10.1186/1479-5876-4-6
-
(2006)
J Transl Med
, vol.4
, pp. 6
-
-
Burleson, K.M.1
Boente, M.P.2
Pambuccian, S.E.3
Skubitz, A.P.4
-
10
-
-
62749197305
-
Multicellular spheroids in ovarian cancer metastases: biology and pathology
-
doi:10.1016/j.ygyno.2008.11.032
-
Shield K, Ackland ML, Ahmed N, Rice GE. Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol (2009) 113(1):143-8. doi:10.1016/j.ygyno.2008.11.032
-
(2009)
Gynecol Oncol
, vol.113
, Issue.1
, pp. 143-148
-
-
Shield, K.1
Ackland, M.L.2
Ahmed, N.3
Rice, G.E.4
-
11
-
-
33750312322
-
Mechanisms of transcoelomic metastasis in ovarian cancer
-
doi:10.1016/S1470-2045(06)70939-1
-
Tan DS, Agarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol (2006) 7(11):925-34. doi:10.1016/S1470-2045(06)70939-1
-
(2006)
Lancet Oncol
, vol.7
, Issue.11
, pp. 925-934
-
-
Tan, D.S.1
Agarwal, R.2
Kaye, S.B.3
-
12
-
-
69249235702
-
Dissemination of intraperitoneal ovarian cancer: discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model
-
doi:10.1016/j.critrevonc.2008.12.003
-
Feki A, Berardi P, Bellingan G, Major A, Krause KH, Petignat P, et al. Dissemination of intraperitoneal ovarian cancer: discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model. Crit Rev Oncol Hematol (2009) 72(1):1-9. doi:10.1016/j.critrevonc.2008.12.003
-
(2009)
Crit Rev Oncol Hematol
, vol.72
, Issue.1
, pp. 1-9
-
-
Feki, A.1
Berardi, P.2
Bellingan, G.3
Major, A.4
Krause, K.H.5
Petignat, P.6
-
13
-
-
0031767724
-
Diagnosing ascitic etiology on a biochemical basis
-
Bansal S, Kaur K, Bansal AK. Diagnosing ascitic etiology on a biochemical basis. Hepatogastroenterology (1998) 45(23):1673-7.
-
(1998)
Hepatogastroenterology
, vol.45
, Issue.23
, pp. 1673-1677
-
-
Bansal, S.1
Kaur, K.2
Bansal, A.K.3
-
14
-
-
0023766008
-
Ascitic fluid analysis in malignancy-related ascites
-
doi:10.1002/hep.1840080521
-
Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology (1988) 8(5):1104-9. doi:10.1002/hep.1840080521
-
(1988)
Hepatology
, vol.8
, Issue.5
, pp. 1104-1109
-
-
Runyon, B.A.1
Hoefs, J.C.2
Morgan, T.R.3
-
15
-
-
0041912752
-
Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy?
-
doi:10.1200/JCO.2003.06.119
-
Kolomainen DF, A'Hern R, Coxon FY, Fisher C, King DM, Blake PR, et al. Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy? J Clin Oncol (2003) 21(16):3113-8. doi:10.1200/JCO.2003.06.119
-
(2003)
J Clin Oncol
, vol.21
, Issue.16
, pp. 3113-3118
-
-
Kolomainen, D.F.1
A'Hern, R.2
Coxon, F.Y.3
Fisher, C.4
King, D.M.5
Blake, P.R.6
-
16
-
-
0016195162
-
Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer
-
Feldman GB, Knapp RC. Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer. Am J Obstet Gynecol (1974) 119(7):991-4.
-
(1974)
Am J Obstet Gynecol
, vol.119
, Issue.7
, pp. 991-994
-
-
Feldman, G.B.1
Knapp, R.C.2
-
17
-
-
2942577573
-
Malignant ascites: past, present, and future
-
doi:10.1016/j.jamcollsurg.2004.01.035
-
Adam RA, Adam YG. Malignant ascites: past, present, and future. J Am Coll Surg (2004) 198(6):999-1011. doi:10.1016/j.jamcollsurg.2004.01.035
-
(2004)
J Am Coll Surg
, vol.198
, Issue.6
, pp. 999-1011
-
-
Adam, R.A.1
Adam, Y.G.2
-
18
-
-
0015385809
-
The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma
-
Feldman GB, Knapp RC, Order SE, Hellman S. The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res (1972) 32(8):1663-6.
-
(1972)
Cancer Res
, vol.32
, Issue.8
, pp. 1663-1666
-
-
Feldman, G.B.1
Knapp, R.C.2
Order, S.E.3
Hellman, S.4
-
19
-
-
0038724683
-
Intraperitoneal cancer dissemination: mechanisms of the patterns of spread
-
doi:10.1023/A:1023791229361
-
Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev (2003) 22(4):465-72. doi:10.1023/A:1023791229361
-
(2003)
Cancer Metastasis Rev
, vol.22
, Issue.4
, pp. 465-472
-
-
Carmignani, C.P.1
Sugarbaker, T.A.2
Bromley, C.M.3
Sugarbaker, P.H.4
-
20
-
-
84878456311
-
Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules
-
doi:10.1073/pnas.1216989110
-
Rizvi I, Gurkan UA, Tasoglu S, Alagic N, Celli JP, Mensah LB, et al. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc Natl Acad Sci U S A (2013) 110(22):E1974-83. doi:10.1073/pnas.1216989110
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, Issue.22
-
-
Rizvi, I.1
Gurkan, U.A.2
Tasoglu, S.3
Alagic, N.4
Celli, J.P.5
Mensah, L.B.6
-
21
-
-
0023754185
-
Peritoneal implants from ovarian tumors: CT findings
-
Buy JN, Moss AA, Ghossain MA, Sciot C, Malbec L, Vadrot D, et al. Peritoneal implants from ovarian tumors: CT findings. Radiology (1988) 169(3):691-4.
-
(1988)
Radiology
, vol.169
, Issue.3
, pp. 691-694
-
-
Buy, J.N.1
Moss, A.A.2
Ghossain, M.A.3
Sciot, C.4
Malbec, L.5
Vadrot, D.6
-
22
-
-
0025011698
-
Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells
-
doi:10.1172/JCI114784
-
Mills GB, May C, Hill M, Campbell S, Shaw P, Marks A. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. J Clin Invest (1990) 86(3):851-5. doi:10.1172/JCI114784
-
(1990)
J Clin Invest
, vol.86
, Issue.3
, pp. 851-855
-
-
Mills, G.B.1
May, C.2
Hill, M.3
Campbell, S.4
Shaw, P.5
Marks, A.6
-
23
-
-
0023860289
-
A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action
-
Mills GB, May C, McGill M, Roifman CM, Mellors A. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. Cancer Res (1988) 48(5):1066-71.
-
(1988)
Cancer Res
, vol.48
, Issue.5
, pp. 1066-1071
-
-
Mills, G.B.1
May, C.2
McGill, M.3
Roifman, C.M.4
Mellors, A.5
-
24
-
-
84870299455
-
Profiling of cytokines in human epithelial ovarian cancer ascites
-
Matte I, Lane D, Laplante C, Rancourt C, Piche A. Profiling of cytokines in human epithelial ovarian cancer ascites. Am J Cancer Res (2012) 2(5):566-80.
-
(2012)
Am J Cancer Res
, vol.2
, Issue.5
, pp. 566-580
-
-
Matte, I.1
Lane, D.2
Laplante, C.3
Rancourt, C.4
Piche, A.5
-
25
-
-
84868676376
-
Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
-
doi:10.1186/1757-2215-5-34
-
Lane D, Matte I, Rancourt C, Piche A. Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis. J Ovarian Res (2012) 5(1):34. doi:10.1186/1757-2215-5-34
-
(2012)
J Ovarian Res
, vol.5
, Issue.1
, pp. 34
-
-
Lane, D.1
Matte, I.2
Rancourt, C.3
Piche, A.4
-
26
-
-
12244271468
-
Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells
-
doi:10.1210/jc.2004-0297
-
Choi JH, Park SH, Leung PC, Choi KC. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J Clin Endocrinol Metab (2005) 90(1):207-10. doi:10.1210/jc.2004-0297
-
(2005)
J Clin Endocrinol Metab
, vol.90
, Issue.1
, pp. 207-210
-
-
Choi, J.H.1
Park, S.H.2
Leung, P.C.3
Choi, K.C.4
-
27
-
-
0034763562
-
Cytokines and immune response in the tumor microenvironment
-
Mocellin S, Wang E, Marincola FM. Cytokines and immune response in the tumor microenvironment. J Immunother (2001) 24(5):392-407.
-
(2001)
J Immunother
, vol.24
, Issue.5
, pp. 392-407
-
-
Mocellin, S.1
Wang, E.2
Marincola, F.M.3
-
28
-
-
0037769110
-
Dendritic cells in immunity and tolerance-do they display opposite functions?
-
doi:10.1016/S1074-7613(03)00182-1
-
Moser M. Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity (2003) 19(1):5-8. doi:10.1016/S1074-7613(03)00182-1
-
(2003)
Immunity
, vol.19
, Issue.1
, pp. 5-8
-
-
Moser, M.1
-
29
-
-
0035062021
-
Interleukin-10 and the interleukin-10 receptor
-
doi:10.1146/annurev.immunol.19.1.683
-
Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 19:683-765. doi:10.1146/annurev.immunol.19.1.683
-
(2001)
Annu Rev Immunol
, vol.19
, pp. 683-765
-
-
Moore, K.W.1
de Waal Malefyt, R.2
Coffman, R.L.3
O'Garra, A.4
-
30
-
-
0043279987
-
Epithelial ovarian cancer cells secrete functional Fas ligand
-
Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, et al. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res (2003) 63(17):5573-81.
-
(2003)
Cancer Res
, vol.63
, Issue.17
, pp. 5573-5581
-
-
Abrahams, V.M.1
Straszewski, S.L.2
Kamsteeg, M.3
Hanczaruk, B.4
Schwartz, P.E.5
Rutherford, T.J.6
-
31
-
-
79551610187
-
Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity
-
doi:10.3892/or.2010.1119
-
Peng P, Yan Y, Keng S. Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity. Oncol Rep (2011) 25(3):749-62. doi:10.3892/or.2010.1119
-
(2011)
Oncol Rep
, vol.25
, Issue.3
, pp. 749-762
-
-
Peng, P.1
Yan, Y.2
Keng, S.3
-
32
-
-
84864842768
-
Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer
-
doi:10.1158/0008-5472.CAN-11-2695
-
Webb TJ, Li X, Giuntoli RL II, Lopez PH, Heuser C, Schnaar RL, et al. Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res (2012) 72(15):3744-52. doi:10.1158/0008-5472.CAN-11-2695
-
(2012)
Cancer Res
, vol.72
, Issue.15
, pp. 3744-3752
-
-
Webb, T.J.1
Li, X.2
Giuntoli I.I, R.L.3
Lopez, P.H.4
Heuser, C.5
Schnaar, R.L.6
-
33
-
-
76749085709
-
MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
-
doi:10.1186/1476-4598-9-11
-
Gubbels JA, Felder M, Horibata S, Belisle JA, Kapur A, Holden H, et al. MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells. Mol Cancer (2010) 9:11. doi:10.1186/1476-4598-9-11
-
(2010)
Mol Cancer
, vol.9
, pp. 11
-
-
Gubbels, J.A.1
Felder, M.2
Horibata, S.3
Belisle, J.A.4
Kapur, A.5
Holden, H.6
-
34
-
-
0033973947
-
IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity
-
Kryczek I, Grybos M, Karabon L, Klimczak A, Lange A. IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity. Br J Cancer (2000) 82(3):621-8.
-
(2000)
Br J Cancer
, vol.82
, Issue.3
, pp. 621-628
-
-
Kryczek, I.1
Grybos, M.2
Karabon, L.3
Klimczak, A.4
Lange, A.5
-
35
-
-
6744262234
-
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
-
doi:10.1046/j.1525-1438.2000.00003.x
-
Penson RT, Kronish K, Duan Z, Feller AJ, Stark P, Cook SE, et al. Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int J Gynecol Cancer (2000) 10(1):33-41. doi:10.1046/j.1525-1438.2000.00003.x
-
(2000)
Int J Gynecol Cancer
, vol.10
, Issue.1
, pp. 33-41
-
-
Penson, R.T.1
Kronish, K.2
Duan, Z.3
Feller, A.J.4
Stark, P.5
Cook, S.E.6
-
36
-
-
0034306969
-
Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8
-
Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res (2000) 60(19):5334-9.
-
(2000)
Cancer Res
, vol.60
, Issue.19
, pp. 5334-5339
-
-
Huang, S.1
Robinson, J.B.2
Deguzman, A.3
Bucana, C.D.4
Fidler, I.J.5
-
37
-
-
0031049172
-
Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma
-
Obata NH, Tamakoshi K, Shibata K, Kikkawa F, Tomoda Y. Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma. Anticancer Res (1997) 17(1A):337-42.
-
(1997)
Anticancer Res
, vol.17
, Issue.1 A
, pp. 337-342
-
-
Obata, N.H.1
Tamakoshi, K.2
Shibata, K.3
Kikkawa, F.4
Tomoda, Y.5
-
38
-
-
0037123348
-
Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells
-
doi:10.1093/jnci/94.8.617
-
Syed V, Ulinski G, Mok SC, Ho SM. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J Natl Cancer Inst (2002) 94(8):617-29. doi:10.1093/jnci/94.8.617
-
(2002)
J Natl Cancer Inst
, vol.94
, Issue.8
, pp. 617-629
-
-
Syed, V.1
Ulinski, G.2
Mok, S.C.3
Ho, S.M.4
-
39
-
-
77953611991
-
Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
-
doi:10.1016/j.canlet.2010.02.019
-
Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, et al. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett (2010) 295(1):110-23. doi:10.1016/j.canlet.2010.02.019
-
(2010)
Cancer Lett
, vol.295
, Issue.1
, pp. 110-123
-
-
Wang, Y.1
Niu, X.L.2
Qu, Y.3
Wu, J.4
Zhu, Y.Q.5
Sun, W.J.6
-
40
-
-
84887911347
-
Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
-
doi:10.1007/s00109-012-0946-4
-
Cohen S, Bruchim I, Graiver D, Evron Z, Oron-Karni V, Pasmanik-Chor M, et al. Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2. J Mol Med (Berl) (2013) 91(3):357-68. doi:10.1007/s00109-012-0946-4
-
(2013)
J Mol Med (Berl)
, vol.91
, Issue.3
, pp. 357-368
-
-
Cohen, S.1
Bruchim, I.2
Graiver, D.3
Evron, Z.4
Oron-Karni, V.5
Pasmanik-Chor, M.6
-
41
-
-
28244475975
-
Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine
-
doi:10.1158/0008-5472.CAN-05-0623
-
Nilsson MB, Langley RR, Fidler IJ. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res (2005) 65(23):10794-800. doi:10.1158/0008-5472.CAN-05-0623
-
(2005)
Cancer Res
, vol.65
, Issue.23
, pp. 10794-10800
-
-
Nilsson, M.B.1
Langley, R.R.2
Fidler, I.J.3
-
42
-
-
0031194467
-
Serum evaluation of interleukin 6 in ovarian cancer patients
-
doi:10.1006/gyno.1997.4726
-
Temfer C, Zeisler H, Sliutz G, Haeusler G, Hanzal E, Kainz C. Serum evaluation of interleukin 6 in ovarian cancer patients. Gynecol Oncol (1997) 66(1):27-30. doi:10.1006/gyno.1997.4726
-
(1997)
Gynecol Oncol
, vol.66
, Issue.1
, pp. 27-30
-
-
Temfer, C.1
Zeisler, H.2
Sliutz, G.3
Haeusler, G.4
Hanzal, E.5
Kainz, C.6
-
43
-
-
0028871101
-
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer
-
doi:10.1038/bjc.1995.71
-
Scambia G, Testa U, Benedetti PP, Foti E, Martucci R, Gadducci A, et al. Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer (1995) 71(2):354-6. doi:10.1038/bjc.1995.71
-
(1995)
Br J Cancer
, vol.71
, Issue.2
, pp. 354-356
-
-
Scambia, G.1
Testa, U.2
Benedetti, P.P.3
Foti, E.4
Martucci, R.5
Gadducci, A.6
-
44
-
-
79957466111
-
Prognostic significance of IL-6 and Il-8 ascites levels in ovarian cancer patients
-
doi:10.1186/1471-2407-11-210
-
Lane D, Matte I, Rancourt C, Pinche A. Prognostic significance of IL-6 and Il-8 ascites levels in ovarian cancer patients. BMC Cancer (2011) 11:210. doi:10.1186/1471-2407-11-210
-
(2011)
BMC Cancer
, vol.11
, pp. 210
-
-
Lane, D.1
Matte, I.2
Rancourt, C.3
Pinche, A.4
-
45
-
-
0028203595
-
Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer
-
doi:10.1002/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R
-
Plante M, Rubin SC, Wong GY, Federici MG, Finstad CL, Gasti GA. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer (1994) 73(7):1882-8. doi:10.1002/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R
-
(1994)
Cancer
, vol.73
, Issue.7
, pp. 1882-1888
-
-
Plante, M.1
Rubin, S.C.2
Wong, G.Y.3
Federici, M.G.4
Finstad, C.L.5
Gasti, G.A.6
-
46
-
-
0032865917
-
Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells
-
doi:10.1002/(SICI)1097-0215(19991112)83:4<476::AID-IJC7>3.0.CO;2-V
-
Sowter HM, Corps AN, Smith SK. Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells. Int J Cancer (1999) 83(4):476-80. doi:10.1002/(SICI)1097-0215(19991112)83:4<476::AID-IJC7>3.0.CO;2-V
-
(1999)
Int J Cancer
, vol.83
, Issue.4
, pp. 476-480
-
-
Sowter, H.M.1
Corps, A.N.2
Smith, S.K.3
-
47
-
-
10744225477
-
Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells
-
doi:10.1074/jbc.M306662200
-
Fang X, Yu S, Bast RC, Liu S, Xu HJ, Hu SX, et al. Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J Biol Chem (2004) 279(10):9653-61. doi:10.1074/jbc.M306662200
-
(2004)
J Biol Chem
, vol.279
, Issue.10
, pp. 9653-9661
-
-
Fang, X.1
Yu, S.2
Bast, R.C.3
Liu, S.4
Xu, H.J.5
Hu, S.X.6
-
48
-
-
0035897531
-
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells
-
doi:10.1093/jnci/93.10.762
-
Hu YL, Tee MK, Goetzl EJ, Auersperg N, Mills GB, Ferrara N, et al. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst (2001) 93(10):762-8. doi:10.1093/jnci/93.10.762
-
(2001)
J Natl Cancer Inst
, vol.93
, Issue.10
, pp. 762-768
-
-
Hu, Y.L.1
Tee, M.K.2
Goetzl, E.J.3
Auersperg, N.4
Mills, G.B.5
Ferrara, N.6
-
49
-
-
84864078672
-
Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells
-
doi:10.1074/jbc.M112.340083
-
Mukherjee A, Wu J, Barbour S, Fang X. Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells. J Biol Chem (2012) 287(30):24990-5000. doi:10.1074/jbc.M112.340083
-
(2012)
J Biol Chem
, vol.287
, Issue.30
, pp. 24990-25000
-
-
Mukherjee, A.1
Wu, J.2
Barbour, S.3
Fang, X.4
-
50
-
-
84861024878
-
Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells
-
doi:10.1155/2012/501492
-
Liu Y, Burkhalter R, Symowicz J, Chaffin K, Ellerbroek S, Stack MS. Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells. J Oncol (2012) 2012:501492. doi:10.1155/2012/501492
-
(2012)
J Oncol
, vol.2012
, pp. 501492
-
-
Liu, Y.1
Burkhalter, R.2
Symowicz, J.3
Chaffin, K.4
Ellerbroek, S.5
Stack, M.S.6
-
51
-
-
1842850792
-
Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients
-
doi:10.1016/j.clinbiochem.2004.01.014
-
Kassim SK, El-Salahy EM, Fayed ST, Helal SA, Helal T, Azzam Eel D, et al. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem (2004) 37(5):363-9. doi:10.1016/j.clinbiochem.2004.01.014
-
(2004)
Clin Biochem
, vol.37
, Issue.5
, pp. 363-369
-
-
Kassim, S.K.1
El-Salahy, E.M.2
Fayed, S.T.3
Helal, S.A.4
Helal, T.5
Azzam Eel, D.6
-
52
-
-
0030923795
-
Vascular endothelial growth factor expression in early stage ovarian carcinoma
-
doi:10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A
-
Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer (1997) 80(1):98-106. doi:10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A
-
(1997)
Cancer
, vol.80
, Issue.1
, pp. 98-106
-
-
Paley, P.J.1
Staskus, K.A.2
Gebhard, K.3
Mohanraj, D.4
Twiggs, L.B.5
Carson, L.F.6
-
53
-
-
0032989564
-
Secretion of vascular endothelial growth factor in ovarian cancer
-
Santin AD, Hermonat PL, Ravaggi A, Cannon MJ, Pecorelli S, Parham GP. Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol (1999) 20(3):177-81.
-
(1999)
Eur J Gynaecol Oncol
, vol.20
, Issue.3
, pp. 177-181
-
-
Santin, A.D.1
Hermonat, P.L.2
Ravaggi, A.3
Cannon, M.J.4
Pecorelli, S.5
Parham, G.P.6
-
54
-
-
0345060442
-
Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model
-
Byrne AT, Ross L, Holash J, Nakanishi M, Hu L, Hofmann JI, et al. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. Clin Cancer Res (2003) 9(15):5721-8.
-
(2003)
Clin Cancer Res
, vol.9
, Issue.15
, pp. 5721-5728
-
-
Byrne, A.T.1
Ross, L.2
Holash, J.3
Nakanishi, M.4
Hu, L.5
Hofmann, J.I.6
-
55
-
-
84865680246
-
VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5
-
doi:10.1016/j.ygyno.2012.05.002
-
Herr D, Sallmann A, Bekes I, Konrad R, Holzheu I, Kreienberg R, et al. VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5. Gynecol Oncol (2012) 127(1):210-6. doi:10.1016/j.ygyno.2012.05.002
-
(2012)
Gynecol Oncol
, vol.127
, Issue.1
, pp. 210-216
-
-
Herr, D.1
Sallmann, A.2
Bekes, I.3
Konrad, R.4
Holzheu, I.5
Kreienberg, R.6
-
56
-
-
0031825437
-
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
-
Esser S, Lampugnani MG, Corada M, Dejana E, Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci (1998) 111(Pt 13):1853-65.
-
(1998)
J Cell Sci
, vol.111
, Issue.PART 13
, pp. 1853-1865
-
-
Esser, S.1
Lampugnani, M.G.2
Corada, M.3
Dejana, E.4
Risau, W.5
-
57
-
-
79953648492
-
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer
-
doi:10.1093/annonc/mdq708
-
Zweifel M, Jayson GC, Reed NS, Osborne R, Hassan B, Ledermann J, et al. Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer. Ann Oncol (2011) 22(9):2036-41. doi:10.1093/annonc/mdq708
-
(2011)
Ann Oncol
, vol.22
, Issue.9
, pp. 2036-2041
-
-
Zweifel, M.1
Jayson, G.C.2
Reed, N.S.3
Osborne, R.4
Hassan, B.5
Ledermann, J.6
-
58
-
-
84891074926
-
Current status of bevacizumab in advanced ovarian cancer
-
doi:10.2147/OTT.S46301
-
Tomao F, Papa A, Rossi L, Caruso D, Panici PB, Venezia M, et al. Current status of bevacizumab in advanced ovarian cancer. Onco Targets Ther (2013) 6:889-99. doi:10.2147/OTT.S46301
-
(2013)
Onco Targets Ther
, vol.6
, pp. 889-899
-
-
Tomao, F.1
Papa, A.2
Rossi, L.3
Caruso, D.4
Panici, P.B.5
Venezia, M.6
-
59
-
-
0035740826
-
Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature
-
Davidson B. Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature. Anal Cell Pathol (2001) 23(3-4):107-28.
-
(2001)
Anal Cell Pathol
, vol.23
, Issue.3-4
, pp. 107-128
-
-
Davidson, B.1
-
60
-
-
84867320871
-
Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors
-
doi:10.1371/journal.pone.0046858
-
Latifi A, Luwor RB, Bilandzic M, Nazaretian S, Stenvers K, Pyman J, et al. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS One (2012) 7(10):e46858. doi:10.1371/journal.pone.0046858
-
(2012)
PLoS One
, vol.7
, Issue.10
-
-
Latifi, A.1
Luwor, R.B.2
Bilandzic, M.3
Nazaretian, S.4
Stenvers, K.5
Pyman, J.6
-
61
-
-
84872676923
-
Ovarian cancer stem cells
-
doi:10.4149/neo_2012_094
-
Zeimet AG, Reimer D, Sopper S, Boesch M, Martowicz A, Roessler J, et al. Ovarian cancer stem cells. Neoplasma (2012) 59(6):747-55. doi:10.4149/neo_2012_094
-
(2012)
Neoplasma
, vol.59
, Issue.6
, pp. 747-755
-
-
Zeimet, A.G.1
Reimer, D.2
Sopper, S.3
Boesch, M.4
Martowicz, A.5
Roessler, J.6
-
62
-
-
77952855239
-
Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer
-
doi:10.2174/156800910791190175
-
Ahmed N, Abubaker K, Findlay J, Quinn M. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets (2010) 10(3):268-78. doi:10.2174/156800910791190175
-
(2010)
Curr Cancer Drug Targets
, vol.10
, Issue.3
, pp. 268-278
-
-
Ahmed, N.1
Abubaker, K.2
Findlay, J.3
Quinn, M.4
-
63
-
-
47549085187
-
Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression
-
doi:10.1007/s10585-008-9171-5
-
Hudson LG, Zeineldin R, Stack MS. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis (2008) 25(6):643-55. doi:10.1007/s10585-008-9171-5
-
(2008)
Clin Exp Metastasis
, vol.25
, Issue.6
, pp. 643-655
-
-
Hudson, L.G.1
Zeineldin, R.2
Stack, M.S.3
-
64
-
-
0033800091
-
Multicellular resistance: a paradigm for clinical resistance?
-
doi:10.1016/S1040-8428(00)00086-X
-
Desoize B, Jardillier J. Multicellular resistance: a paradigm for clinical resistance? Crit Rev Oncol Hematol (2000) 36(2-3):193-207. doi:10.1016/S1040-8428(00)00086-X
-
(2000)
Crit Rev Oncol Hematol
, vol.36
, Issue.2-3
, pp. 193-207
-
-
Desoize, B.1
Jardillier, J.2
-
65
-
-
84876489727
-
Cancer stem cells: the challenges ahead
-
doi:10.1038/ncb2717
-
Medema JP. Cancer stem cells: the challenges ahead. Nat Cell Biol (2013) 15(4):338-44. doi:10.1038/ncb2717
-
(2013)
Nat Cell Biol
, vol.15
, Issue.4
, pp. 338-344
-
-
Medema, J.P.1
-
66
-
-
84865558583
-
Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches
-
doi:10.1007/s12015-011-9344-5
-
Aguilar-Gallardo C, Rutledge EC, Martinez-Arroyo AM, Hidalgo JJ, Domingo S, Simon C. Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches. Stem Cell Rev (2012) 8(3):994-1010. doi:10.1007/s12015-011-9344-5
-
(2012)
Stem Cell Rev
, vol.8
, Issue.3
, pp. 994-1010
-
-
Aguilar-Gallardo, C.1
Rutledge, E.C.2
Martinez-Arroyo, A.M.3
Hidalgo, J.J.4
Domingo, S.5
Simon, C.6
-
67
-
-
84869445970
-
Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance
-
doi:10.1002/jcb.24317
-
Ahmed N, Abubaker K, Findlay J, Quinn M. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance. J Cell Biochem (2013) 114(1):21-34. doi:10.1002/jcb.24317
-
(2013)
J Cell Biochem
, vol.114
, Issue.1
, pp. 21-34
-
-
Ahmed, N.1
Abubaker, K.2
Findlay, J.3
Quinn, M.4
-
68
-
-
79961006281
-
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
-
doi:10.1172/JCI45273
-
McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest (2011) 121(8):3206-19. doi:10.1172/JCI45273
-
(2011)
J Clin Invest
, vol.121
, Issue.8
, pp. 3206-3219
-
-
McLean, K.1
Gong, Y.2
Choi, Y.3
Deng, N.4
Yang, K.5
Bai, S.6
-
69
-
-
84906963524
-
Ovarian cancer stem cells: molecular concepts and relevance as therapeutic targets
-
doi:10.1016/j.mam.2013.06.002
-
Ahmed N, Abubaker K, Findlay JK. Ovarian cancer stem cells: molecular concepts and relevance as therapeutic targets. Mol Aspects Med (2013). doi:10.1016/j.mam.2013.06.002
-
(2013)
Mol Aspects Med
-
-
Ahmed, N.1
Abubaker, K.2
Findlay, J.K.3
-
70
-
-
41149148789
-
The impact of T-cell immunity on ovarian cancer outcomes
-
doi:10.1111/j.1600-065X.2008.00614.x
-
Nelson BH. The impact of T-cell immunity on ovarian cancer outcomes. Immunol Rev (2008) 222:101-16. doi:10.1111/j.1600-065X.2008.00614.x
-
(2008)
Immunol Rev
, vol.222
, pp. 101-116
-
-
Nelson, B.H.1
-
71
-
-
40749136616
-
Immunotherapy opportunities in ovarian cancer
-
doi:10.1586/14737140.8.2.243
-
Chu CS, Kim SH, June CH, Coukos G. Immunotherapy opportunities in ovarian cancer. Expert Rev Anticancer Ther (2008) 8(2):243-57. doi:10.1586/14737140.8.2.243
-
(2008)
Expert Rev Anticancer Ther
, vol.8
, Issue.2
, pp. 243-257
-
-
Chu, C.S.1
Kim, S.H.2
June, C.H.3
Coukos, G.4
-
72
-
-
78650973754
-
Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines
-
doi:10.1371/journal.pone.0015625
-
Tran E, Nielsen JS, Wick DA, Ng AV, Johnson LD, Nesslinger NJ, et al. Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines. PLoS One (2010) 5(12):e15625. doi:10.1371/journal.pone.0015625
-
(2010)
PLoS One
, vol.5
, Issue.12
-
-
Tran, E.1
Nielsen, J.S.2
Wick, D.A.3
Ng, A.V.4
Johnson, L.D.5
Nesslinger, N.J.6
-
73
-
-
77953409587
-
Ovarian tumor-induced T cell suppression is alleviated by vascular leukocyte depletion
-
Peter S, Bak G, Hart K, Berwin B. Ovarian tumor-induced T cell suppression is alleviated by vascular leukocyte depletion. Transl Oncol (2009) 2(4):291-9.
-
(2009)
Transl Oncol
, vol.2
, Issue.4
, pp. 291-299
-
-
Peter, S.1
Bak, G.2
Hart, K.3
Berwin, B.4
-
74
-
-
68549132400
-
Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity
-
Giuntoli RL II, Webb TJ, Zoso A, Rogers O, Diaz-Montes TP, Bristow RE, et al. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res (2009) 29(8):2875-84.
-
(2009)
Anticancer Res
, vol.29
, Issue.8
, pp. 2875-2884
-
-
Giuntoli I.I, R.L.1
Webb, T.J.2
Zoso, A.3
Rogers, O.4
Diaz-Montes, T.P.5
Bristow, R.E.6
-
75
-
-
58149303099
-
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
-
doi:10.1007/s00262-008-0583-5
-
Leffers N, Gooden MJ, de Jong RA, Hoogeboom BN, ten Hoor KA, Hollema H, et al. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother (2009) 58(3):449-59. doi:10.1007/s00262-008-0583-5
-
(2009)
Cancer Immunol Immunother
, vol.58
, Issue.3
, pp. 449-459
-
-
Leffers, N.1
Gooden, M.J.2
de Jong, R.A.3
Hoogeboom, B.N.4
ten Hoor, K.A.5
Hollema, H.6
-
76
-
-
34250159834
-
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance
-
doi:10.1016/j.ygyno.2007.02.029
-
Bamias A, Tsiatas ML, Kafantari E, Liakou C, Rodolakis A, Voulgaris Z, et al. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance. Gynecol Oncol (2007) 106(1):75-81. doi:10.1016/j.ygyno.2007.02.029
-
(2007)
Gynecol Oncol
, vol.106
, Issue.1
, pp. 75-81
-
-
Bamias, A.1
Tsiatas, M.L.2
Kafantari, E.3
Liakou, C.4
Rodolakis, A.5
Voulgaris, Z.6
-
77
-
-
69849107597
-
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
-
doi:10.1182/blood-2009-03-208249
-
Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood (2009) 114(6):1141-9. doi:10.1182/blood-2009-03-208249
-
(2009)
Blood
, vol.114
, Issue.6
, pp. 1141-1149
-
-
Kryczek, I.1
Banerjee, M.2
Cheng, P.3
Vatan, L.4
Szeliga, W.5
Wei, S.6
-
78
-
-
84885951882
-
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse
-
doi:10.1002/ijc.28335
-
Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM, Meissner W, et al. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer (2013). doi:10.1002/ijc.28335
-
(2013)
Int J Cancer
-
-
Reinartz, S.1
Schumann, T.2
Finkernagel, F.3
Wortmann, A.4
Jansen, J.M.5
Meissner, W.6
-
79
-
-
20444485236
-
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma
-
doi:10.1158/0008-5472.CAN-04-4043
-
Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P, et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res (2005) 65(12):5020-6. doi:10.1158/0008-5472.CAN-04-4043
-
(2005)
Cancer Res
, vol.65
, Issue.12
, pp. 5020-5026
-
-
Wei, S.1
Kryczek, I.2
Zou, L.3
Daniel, B.4
Cheng, P.5
Mottram, P.6
-
80
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
doi:10.1038/nm1093
-
Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 10(9):942-9. doi:10.1038/nm1093
-
(2004)
Nat Med
, vol.10
, Issue.9
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
-
81
-
-
4143064951
-
Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer
-
doi:10.1158/0008-5472.CAN-04-1272
-
Curiel TJ, Cheng P, Mottram P, Alvarez X, Moons L, Evdemon-Hogan M, et al. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res (2004) 64(16):5535-8. doi:10.1158/0008-5472.CAN-04-1272
-
(2004)
Cancer Res
, vol.64
, Issue.16
, pp. 5535-5538
-
-
Curiel, T.J.1
Cheng, P.2
Mottram, P.3
Alvarez, X.4
Moons, L.5
Evdemon-Hogan, M.6
-
82
-
-
66149118659
-
Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism
-
doi:10.1158/0008-5472.CAN-08-2826
-
Norian LA, Rodriguez PC, O'Mara LA, Zabaleta J, Ochoa AC, Cella M, et al. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res (2009) 69(7):3086-94. doi:10.1158/0008-5472.CAN-08-2826
-
(2009)
Cancer Res
, vol.69
, Issue.7
, pp. 3086-3094
-
-
Norian, L.A.1
Rodriguez, P.C.2
O'Mara, L.A.3
Zabaleta, J.4
Ochoa, A.C.5
Cella, M.6
-
83
-
-
61349100687
-
Myeloid-derived suppressor cells as regulators of the immune system
-
doi:10.1038/nri2506
-
Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 9(3):162-74. doi:10.1038/nri2506
-
(2009)
Nat Rev Immunol
, vol.9
, Issue.3
, pp. 162-174
-
-
Gabrilovich, D.I.1
Nagaraj, S.2
-
84
-
-
66949141951
-
Microenvironmental regulation of ovarian cancer metastasis
-
doi:10.1007/978-0-387-98094-2_15
-
Barbolina MV, Moss NM, Westfall SD, Liu Y, Burkhalter RJ, Marga F, et al. Microenvironmental regulation of ovarian cancer metastasis. Cancer Treat Res (2009) 149:319-34. doi:10.1007/978-0-387-98094-2_15
-
(2009)
Cancer Treat Res
, vol.149
, pp. 319-334
-
-
Barbolina, M.V.1
Moss, N.M.2
Westfall, S.D.3
Liu, Y.4
Burkhalter, R.J.5
Marga, F.6
-
85
-
-
79951852902
-
Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion
-
doi:10.1016/j.canlet.2011.01.011
-
Zhang Y, Tang H, Cai J, Zhang T, Guo J, Feng D, et al. Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett (2011) 303(1):47-55. doi:10.1016/j.canlet.2011.01.011
-
(2011)
Cancer Lett
, vol.303
, Issue.1
, pp. 47-55
-
-
Zhang, Y.1
Tang, H.2
Cai, J.3
Zhang, T.4
Guo, J.5
Feng, D.6
-
86
-
-
84855393328
-
Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness
-
doi:10.1093/carcin/bgr230
-
Cai J, Tang H, Xu L, Wang X, Yang C, Ruan S, et al. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis (2012) 33(1):20-9. doi:10.1093/carcin/bgr230
-
(2012)
Carcinogenesis
, vol.33
, Issue.1
, pp. 20-29
-
-
Cai, J.1
Tang, H.2
Xu, L.3
Wang, X.4
Yang, C.5
Ruan, S.6
-
87
-
-
84875684114
-
Interleukin-1beta promotes ovarian tumorigenesis through a p53/NF-kappaB-mediated inflammatory response in stromal fibroblasts
-
Schauer IG, Zhang J, Xing Z, Guo X, Mercado-Uribe I, Sood AK, et al. Interleukin-1beta promotes ovarian tumorigenesis through a p53/NF-kappaB-mediated inflammatory response in stromal fibroblasts. Neoplasia (2013) 15(4):409-20.
-
(2013)
Neoplasia
, vol.15
, Issue.4
, pp. 409-420
-
-
Schauer, I.G.1
Zhang, J.2
Xing, Z.3
Guo, X.4
Mercado-Uribe, I.5
Sood, A.K.6
-
88
-
-
64549145804
-
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression
-
doi:10.1371/journal.pone.0004992
-
Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One (2009) 4(4):e4992. doi:10.1371/journal.pone.0004992
-
(2009)
PLoS One
, vol.4
, Issue.4
-
-
Spaeth, E.L.1
Dembinski, J.L.2
Sasser, A.K.3
Watson, K.4
Klopp, A.5
Hall, B.6
-
89
-
-
84870895812
-
Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment
-
doi:10.1039/c2lc40887b
-
Businaro L, De Ninno A, Schiavoni G, Lucarini V, Ciasca G, Gerardino A, et al. Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. Lab Chip (2013) 13(2):229-39. doi:10.1039/c2lc40887b
-
(2013)
Lab Chip
, vol.13
, Issue.2
, pp. 229-239
-
-
Businaro, L.1
De Ninno, A.2
Schiavoni, G.3
Lucarini, V.4
Ciasca, G.5
Gerardino, A.6
-
90
-
-
20444486841
-
Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions
-
doi:10.1016/j.ygyno.2005.02.017
-
Stadlmann S, Amberger A, Pollheimer J, Gastl G, Offner FA, Margreiter R, et al. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions. Gynecol Oncol (2005) 97(3):784-9. doi:10.1016/j.ygyno.2005.02.017
-
(2005)
Gynecol Oncol
, vol.97
, Issue.3
, pp. 784-789
-
-
Stadlmann, S.1
Amberger, A.2
Pollheimer, J.3
Gastl, G.4
Offner, F.A.5
Margreiter, R.6
-
91
-
-
34848888380
-
Possible involvement of SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of migratory potential in human peritoneal mesothelial cells
-
doi:10.1007/s00441-007-0455-x
-
Kajiyama H, Shibata K, Ino K, Nawa A, Mizutani S, Kikkawa F. Possible involvement of SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of migratory potential in human peritoneal mesothelial cells. Cell Tissue Res (2007) 330(2):221-9. doi:10.1007/s00441-007-0455-x
-
(2007)
Cell Tissue Res
, vol.330
, Issue.2
, pp. 221-229
-
-
Kajiyama, H.1
Shibata, K.2
Ino, K.3
Nawa, A.4
Mizutani, S.5
Kikkawa, F.6
-
92
-
-
79955002720
-
Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer
-
doi:10.2741/3693
-
Curley MD, Garrett LA, Schorge JO, Foster R, Rueda BR. Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer. Front Biosci (2011) 16:368-92. doi:10.2741/3693
-
(2011)
Front Biosci
, vol.16
, pp. 368-392
-
-
Curley, M.D.1
Garrett, L.A.2
Schorge, J.O.3
Foster, R.4
Rueda, B.R.5
-
93
-
-
17144403478
-
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
-
Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res (2005) 65(8):3025-9.
-
(2005)
Cancer Res
, vol.65
, Issue.8
, pp. 3025-3029
-
-
Bapat, S.A.1
Mali, A.M.2
Koppikar, C.B.3
Kurrey, N.K.4
-
94
-
-
49249091523
-
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
-
doi:10.1158/0008-5472.CAN-08-0364
-
Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res (2008) 68(11):4311-20. doi:10.1158/0008-5472.CAN-08-0364
-
(2008)
Cancer Res
, vol.68
, Issue.11
, pp. 4311-4320
-
-
Zhang, S.1
Balch, C.2
Chan, M.W.3
Lai, H.C.4
Matei, D.5
Schilder, J.M.6
-
95
-
-
0037388204
-
Prospective identification of tumorigenic breast cancer cells
-
doi:10.1073/pnas.0530291100
-
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 100(7):3983-8. doi:10.1073/pnas.0530291100
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, Issue.7
, pp. 3983-3988
-
-
Al-Hajj, M.1
Wicha, M.S.2
Benito-Hernandez, A.3
Morrison, S.J.4
Clarke, M.F.5
-
96
-
-
0141842674
-
Identification of a cancer stem cell in human brain tumors
-
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 63(18):5821-8.
-
(2003)
Cancer Res
, vol.63
, Issue.18
, pp. 5821-5828
-
-
Singh, S.K.1
Clarke, I.D.2
Terasaki, M.3
Bonn, V.E.4
Hawkins, C.5
Squire, J.6
-
97
-
-
84865056040
-
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
-
doi:10.1186/1471-2407-12-359
-
Wintzell M, Hjerpe E, Avall Lundqvist E, Shoshan M. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites. BMC Cancer (2012) 12:359. doi:10.1186/1471-2407-12-359
-
(2012)
BMC Cancer
, vol.12
, pp. 359
-
-
Wintzell, M.1
Hjerpe, E.2
Avall Lundqvist, E.3
Shoshan, M.4
-
98
-
-
33846029123
-
A perivascular niche for brain tumor stem cells
-
doi:10.1016/j.ccr.2006.11.020
-
Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11(1):69-82. doi:10.1016/j.ccr.2006.11.020
-
(2007)
Cancer Cell
, vol.11
, Issue.1
, pp. 69-82
-
-
Calabrese, C.1
Poppleton, H.2
Kocak, M.3
Hogg, T.L.4
Fuller, C.5
Hamner, B.6
-
99
-
-
84880291315
-
Evaluating cell lines as tumour models by comparison of genomic profiles
-
doi:10.1038/ncomms3126
-
Domcke S, Sinha R, Levine DA, Sander C, Schultz N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun (2013) 4:2126. doi:10.1038/ncomms3126
-
(2013)
Nat Commun
, vol.4
, pp. 2126
-
-
Domcke, S.1
Sinha, R.2
Levine, D.A.3
Sander, C.4
Schultz, N.5
-
100
-
-
34447345507
-
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients
-
doi:10.1038/nprot.2006.328
-
Shepherd TG, Theriault BL, Campbell EJ, Nachtigal MW. Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc (2006) 1(6):2643-9. doi:10.1038/nprot.2006.328
-
(2006)
Nat Protoc
, vol.1
, Issue.6
, pp. 2643-2649
-
-
Shepherd, T.G.1
Theriault, B.L.2
Campbell, E.J.3
Nachtigal, M.W.4
-
101
-
-
84857019139
-
Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma
-
doi:10.1186/1423-0127-19-23
-
Ho CM, Chang SF, Hsiao CC, Chien TY, Shih DT. Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma. J Biomed Sci (2012) 19:23. doi:10.1186/1423-0127-19-23
-
(2012)
J Biomed Sci
, vol.19
, pp. 23
-
-
Ho, C.M.1
Chang, S.F.2
Hsiao, C.C.3
Chien, T.Y.4
Shih, D.T.5
-
102
-
-
84855857047
-
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer
-
doi:10.1371/journal.pone.0029079
-
Vathipadiekal V, Saxena D, Mok SC, Hauschka PV, Ozbun L, Birrer MJ. Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS One (2012) 7(1):e29079. doi:10.1371/journal.pone.0029079
-
(2012)
PLoS One
, vol.7
, Issue.1
-
-
Vathipadiekal, V.1
Saxena, D.2
Mok, S.C.3
Hauschka, P.V.4
Ozbun, L.5
Birrer, M.J.6
-
103
-
-
77950862035
-
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
-
doi:10.1038/sj.bjc.6605626
-
Hu L, McArthur C, Jaffe RB. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer (2010) 102(8):1276-83. doi:10.1038/sj.bjc.6605626
-
(2010)
Br J Cancer
, vol.102
, Issue.8
, pp. 1276-1283
-
-
Hu, L.1
McArthur, C.2
Jaffe, R.B.3
-
104
-
-
77954196772
-
Human ovarian cancer stem cells
-
doi:10.1530/REP-09-0389
-
Bapat SA. Human ovarian cancer stem cells. Reproduction (2010) 140(1):33-41. doi:10.1530/REP-09-0389
-
(2010)
Reproduction
, vol.140
, Issue.1
, pp. 33-41
-
-
Bapat, S.A.1
-
105
-
-
84875320058
-
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
-
doi:10.1186/1476-4598-12-24
-
Abubaker K, Latifi A, Luwor R, Nazaretian S, Zhu H, Quinn MA, et al. Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer (2013) 12(1):24. doi:10.1186/1476-4598-12-24
-
(2013)
Mol Cancer
, vol.12
, Issue.1
, pp. 24
-
-
Abubaker, K.1
Latifi, A.2
Luwor, R.3
Nazaretian, S.4
Zhu, H.5
Quinn, M.A.6
-
106
-
-
60749103183
-
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
-
doi:10.4161/cc.8.1.7533
-
Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle (2009) 8(1):158-66. doi:10.4161/cc.8.1.7533
-
(2009)
Cell Cycle
, vol.8
, Issue.1
, pp. 158-166
-
-
Alvero, A.B.1
Chen, R.2
Fu, H.H.3
Montagna, M.4
Schwartz, P.E.5
Rutherford, T.6
-
107
-
-
80053211466
-
Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
-
doi:10.1002/jcb.23199
-
Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, Dobill F, et al. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. J Cell Biochem (2011) 112:2850-64. doi:10.1002/jcb.23199
-
(2011)
J Cell Biochem
, vol.112
, pp. 2850-2864
-
-
Latifi, A.1
Abubaker, K.2
Castrechini, N.3
Ward, A.C.4
Liongue, C.5
Dobill, F.6
-
108
-
-
84887492120
-
Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical sub-classes in high-grade serous ovarian carcinoma
-
doi:10.1002/ijc.28371
-
Tang Z, Ow GS, Thiery JP, Ivshina AV, Kuznetsov VA. Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical sub-classes in high-grade serous ovarian carcinoma. Int J Cancer (2013). doi:10.1002/ijc.28371
-
(2013)
Int J Cancer
-
-
Tang, Z.1
Ow, G.S.2
Thiery, J.P.3
Ivshina, A.V.4
Kuznetsov, V.A.5
-
109
-
-
84866251102
-
Advances in the formation, use and understanding of multi-cellular spheroids
-
doi:10.1517/14712598.2012.707181
-
Achilli TM, Meyer J, Morgan JR. Advances in the formation, use and understanding of multi-cellular spheroids. Expert Opin Biol Ther (2012) 12(10):1347-60. doi:10.1517/14712598.2012.707181
-
(2012)
Expert Opin Biol Ther
, vol.12
, Issue.10
, pp. 1347-1360
-
-
Achilli, T.M.1
Meyer, J.2
Morgan, J.R.3
-
110
-
-
84865453325
-
The multicellular tumor spheroid model for high-throughput cancer drug discovery
-
doi:10.1517/17460441.2012.708334
-
LaBarbera DV, Reid BG, Yoo BH. The multicellular tumor spheroid model for high-throughput cancer drug discovery. Expert Opin Drug Discov (2012) 7(9):819-30. doi:10.1517/17460441.2012.708334
-
(2012)
Expert Opin Drug Discov
, vol.7
, Issue.9
, pp. 819-830
-
-
LaBarbera, D.V.1
Reid, B.G.2
Yoo, B.H.3
-
111
-
-
34547141141
-
Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis
-
doi:10.1186/1477-3163-6-11
-
Shield K, Riley C, Quinn MA, Rice GE, Ackland ML, Ahmed N. Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. J Carcinog (2007) 6:11. doi:10.1186/1477-3163-6-11
-
(2007)
J Carcinog
, vol.6
, pp. 11
-
-
Shield, K.1
Riley, C.2
Quinn, M.A.3
Rice, G.E.4
Ackland, M.L.5
Ahmed, N.6
-
112
-
-
84859579201
-
Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity
-
doi:10.1016/j.ygyno.2012.01.048
-
Correa RJ, Komar M, Tong JG, Sivapragasam M, Rahman MM, McFadden G, et al. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity. Gynecol Oncol (2012) 125(2):441-50. doi:10.1016/j.ygyno.2012.01.048
-
(2012)
Gynecol Oncol
, vol.125
, Issue.2
, pp. 441-450
-
-
Correa, R.J.1
Komar, M.2
Tong, J.G.3
Sivapragasam, M.4
Rahman, M.M.5
McFadden, G.6
-
113
-
-
84862313384
-
Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis
-
doi:10.1007/s10555-012-9351-2
-
Sodek KL, Murphy KJ, Brown TJ, Ringuette MJ. Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev (2012) 31(1-2):397-414. doi:10.1007/s10555-012-9351-2
-
(2012)
Cancer Metastasis Rev
, vol.31
, Issue.1-2
, pp. 397-414
-
-
Sodek, K.L.1
Murphy, K.J.2
Brown, T.J.3
Ringuette, M.J.4
-
114
-
-
73949158295
-
Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins
-
Tzuman YC, Sapoznik S, Granot D, Nevo N, Neeman M. Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins. Neoplasia (2010) 12(1):51-60.
-
(2010)
Neoplasia
, vol.12
, Issue.1
, pp. 51-60
-
-
Tzuman, Y.C.1
Sapoznik, S.2
Granot, D.3
Nevo, N.4
Neeman, M.5
-
115
-
-
84857849160
-
In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis
-
doi:10.3791/3888
-
Davidowitz RA, Iwanicki MP, Brugge JS. In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis. J Vis Exp (2012) 60:e3888. doi:10.3791/3888
-
(2012)
J Vis Exp
, vol.60
-
-
Davidowitz, R.A.1
Iwanicki, M.P.2
Brugge, J.S.3
-
116
-
-
66949174192
-
Organotypic models of metastasis: a three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis
-
doi:10.1007/978-0-387-98094-2_16
-
Kenny HA, Dogan S, Zillhardt M, Mitra AK, Yamada SD, Krausz T, et al. Organotypic models of metastasis: a three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis. Cancer Treat Res (2009) 149:335-51. doi:10.1007/978-0-387-98094-2_16
-
(2009)
Cancer Treat Res
, vol.149
, pp. 335-351
-
-
Kenny, H.A.1
Dogan, S.2
Zillhardt, M.3
Mitra, A.K.4
Yamada, S.D.5
Krausz, T.6
-
117
-
-
81255157465
-
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
-
doi:10.1038/nm.2492
-
Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med (2011) 17(11):1498-503. doi:10.1038/nm.2492
-
(2011)
Nat Med
, vol.17
, Issue.11
, pp. 1498-1503
-
-
Nieman, K.M.1
Kenny, H.A.2
Penicka, C.V.3
Ladanyi, A.4
Buell-Gutbrod, R.5
Zillhardt, M.R.6
-
118
-
-
62449220684
-
MMP-2 functions as an early response protein in ovarian cancer metastasis
-
doi:10.4161/cc.8.5.7703
-
Kenny HA, Lengyel E. MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle (2009) 8(5):683-8. doi:10.4161/cc.8.5.7703
-
(2009)
Cell Cycle
, vol.8
, Issue.5
, pp. 683-688
-
-
Kenny, H.A.1
Lengyel, E.2
-
119
-
-
69449096005
-
Heterogeneity in cancer: cancer stem cells versus clonal evolution
-
doi:10.1016/j.cell.2009.08.017
-
Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell (2009) 138(5):822-9. doi:10.1016/j.cell.2009.08.017
-
(2009)
Cell
, vol.138
, Issue.5
, pp. 822-829
-
-
Shackleton, M.1
Quintana, E.2
Fearon, E.R.3
Morrison, S.J.4
-
120
-
-
58849134940
-
Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations
-
doi:10.1158/1078-0432.CCR-08-1233
-
Katz E, Skorecki K, Tzukerman M. Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations. Clin Cancer Res (2009) 15(1):70-80. doi:10.1158/1078-0432.CCR-08-1233
-
(2009)
Clin Cancer Res
, vol.15
, Issue.1
, pp. 70-80
-
-
Katz, E.1
Skorecki, K.2
Tzukerman, M.3
-
121
-
-
19944423801
-
Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers
-
doi:10.1007/s10585-004-5768-5
-
Burleson KM, Hansen LK, Skubitz AP. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Clin Exp Metastasis (2004) 21(8):685-97. doi:10.1007/s10585-004-5768-5
-
(2004)
Clin Exp Metastasis
, vol.21
, Issue.8
, pp. 685-697
-
-
Burleson, K.M.1
Hansen, L.K.2
Skubitz, A.P.3
-
122
-
-
81755174100
-
Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions
-
doi:10.1021/mp200240a
-
Gillet JP, Wang J, Calcagno AM, Green LJ, Varma S, Bunkholt Elstrand M, et al. Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions. Mol Pharm (2011) 8(6):2080-8. doi:10.1021/mp200240a
-
(2011)
Mol Pharm
, vol.8
, Issue.6
, pp. 2080-2088
-
-
Gillet, J.P.1
Wang, J.2
Calcagno, A.M.3
Green, L.J.4
Varma, S.5
Bunkholt Elstrand, M.6
-
123
-
-
28444458895
-
Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer
-
doi:10.1002/pmic.200401321
-
Ahmed N, Oliva KT, Barker G, Hoffmann P, Reeve S, Smith IA, et al. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer. Proteomics (2005) 5(17):4625-36. doi:10.1002/pmic.200401321
-
(2005)
Proteomics
, vol.5
, Issue.17
, pp. 4625-4636
-
-
Ahmed, N.1
Oliva, K.T.2
Barker, G.3
Hoffmann, P.4
Reeve, S.5
Smith, I.A.6
-
124
-
-
32944461237
-
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling
-
doi:10.1158/1078-0432.CCR-05-2516
-
Davidson B, Espina V, Steinberg SM, Florenes VA, Liotta LA, Kristensen GB, et al. Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res (2006) 12(3 Pt 1):791-9. doi:10.1158/1078-0432.CCR-05-2516
-
(2006)
Clin Cancer Res
, vol.12
, Issue.3 PART 1
, pp. 791-799
-
-
Davidson, B.1
Espina, V.2
Steinberg, S.M.3
Florenes, V.A.4
Liotta, L.A.5
Kristensen, G.B.6
-
125
-
-
84863794715
-
The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer
-
doi:10.1158/1535-7163.MCT-11-0996
-
Carden CP, Stewart A, Thavasu P, Kipps E, Pope L, Crespo M, et al. The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer. Mol Cancer Ther (2012) 11(7):1609-17. doi:10.1158/1535-7163.MCT-11-0996
-
(2012)
Mol Cancer Ther
, vol.11
, Issue.7
, pp. 1609-1617
-
-
Carden, C.P.1
Stewart, A.2
Thavasu, P.3
Kipps, E.4
Pope, L.5
Crespo, M.6
-
126
-
-
84859416701
-
Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancer
-
doi:10.1158/2159-8290.CD-11-0323
-
Bast RC Jr, Mills GB. Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancer. Cancer Discov (2012) 2(1):16-8. doi:10.1158/2159-8290.CD-11-0323
-
(2012)
Cancer Discov
, vol.2
, Issue.1
, pp. 16-18
-
-
Bast Jr., R.C.1
Mills, G.B.2
-
127
-
-
68249096784
-
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
-
doi:10.1038/ncb1909
-
Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol (2009) 11(8):973-9. doi:10.1038/ncb1909
-
(2009)
Nat Cell Biol
, vol.11
, Issue.8
, pp. 973-979
-
-
Rodier, F.1
Coppe, J.P.2
Patil, C.K.3
Hoeijmakers, W.A.4
Munoz, D.P.5
Raza, S.R.6
-
128
-
-
51649109943
-
Chemotherapeutic drugs and human tumor cells cytokine network
-
doi:10.1002/ijc.23732
-
Levina V, Su Y, Nolen B, Liu X, Gordin Y, Lee M, et al. Chemotherapeutic drugs and human tumor cells cytokine network. Int J Cancer (2008) 123(9):2031-40. doi:10.1002/ijc.23732
-
(2008)
Int J Cancer
, vol.123
, Issue.9
, pp. 2031-2040
-
-
Levina, V.1
Su, Y.2
Nolen, B.3
Liu, X.4
Gordin, Y.5
Lee, M.6
-
129
-
-
63649092087
-
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes
-
doi:10.1016/j.canlet.2008.12.028
-
Keller S, Konig AK, Marme F, Runz S, Wolterink S, Koensgen D, et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett (2009) 278(1):73-81. doi:10.1016/j.canlet.2008.12.028
-
(2009)
Cancer Lett
, vol.278
, Issue.1
, pp. 73-81
-
-
Keller, S.1
Konig, A.K.2
Marme, F.3
Runz, S.4
Wolterink, S.5
Koensgen, D.6
-
130
-
-
36348935057
-
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM
-
doi:10.1016/j.ygyno.2007.08.064
-
Runz S, Keller S, Rupp C, Stoeck A, Issa Y, Koensgen D, et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol (2007) 107(3):563-71. doi:10.1016/j.ygyno.2007.08.064
-
(2007)
Gynecol Oncol
, vol.107
, Issue.3
, pp. 563-571
-
-
Runz, S.1
Keller, S.2
Rupp, C.3
Stoeck, A.4
Issa, Y.5
Koensgen, D.6
-
131
-
-
77953388922
-
The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer
-
doi:10.1186/1757-2215-3-1
-
Lane D, Matte I, Rancourt C, Piche A. The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer. J Ovarian Res (2010) 3:1. doi:10.1186/1757-2215-3-1
-
(2010)
J Ovarian Res
, vol.3
, pp. 1
-
-
Lane, D.1
Matte, I.2
Rancourt, C.3
Piche, A.4
-
132
-
-
79952641187
-
Activated T lymphocytes migrate toward the cathode of DC electric fields in microfluidic devices
-
doi:10.1039/c0lc00371a
-
Li J, Nandagopal S, Wu D, Romanuik SF, Paul K, Thomson DJ, et al. Activated T lymphocytes migrate toward the cathode of DC electric fields in microfluidic devices. Lab Chip (2011) 11(7):1298-304. doi:10.1039/c0lc00371a
-
(2011)
Lab Chip
, vol.11
, Issue.7
, pp. 1298-1304
-
-
Li, J.1
Nandagopal, S.2
Wu, D.3
Romanuik, S.F.4
Paul, K.5
Thomson, D.J.6
-
133
-
-
34547915950
-
Microfluidic reveals generation of platelet-strings on tumor-activated endothelium
-
Goerge T, Kleineruschkamp F, Barg A, Schnaeker EM, Huck V, Schneider MF, et al. Microfluidic reveals generation of platelet-strings on tumor-activated endothelium. Thromb Haemost (2007) 98(2):283-6.
-
(2007)
Thromb Haemost
, vol.98
, Issue.2
, pp. 283-286
-
-
Goerge, T.1
Kleineruschkamp, F.2
Barg, A.3
Schnaeker, E.M.4
Huck, V.5
Schneider, M.F.6
-
134
-
-
70449465250
-
Genomic and personalized medicine: foundations and applications
-
doi:10.1016/j.trsl.2009.09.005
-
Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res (2009) 154(6):277-87. doi:10.1016/j.trsl.2009.09.005
-
(2009)
Transl Res
, vol.154
, Issue.6
, pp. 277-287
-
-
Ginsburg, G.S.1
Willard, H.F.2
|